| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |